HB Wealth Management LLC lowered its stake in Novo Nordisk A/S (NYSE:NVO – Free Report) by 10.3% during the second quarter, according to its most recent disclosure with…
Read more Novo Nordisk A/S $NVO Shares Sold by HB Wealth Management LLCPfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost significant weight but had…
Read more Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effectsStill life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. …
Read more Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart eventsGame-changing anti-obesity medications have posed nothing short of an existential crisis for Weight Watchers parent WW International since they arrived on the scene, but CEO Sima Sistani has…
Read more The Ozempic effect has battered this weight loss stock, but Morgan Stanley says it’s a top pickOmar Marques | Lightrocket | Getty Images This report is from today’s CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed…
Read more CNBC Daily Open: Oil deals ahead of Big Tech earningsTraders work on the floor of the New York Stock Exchange on April 26, 2023 in New York City. Michael M. Santiago | Getty Images This report is…
Read more CNBC Daily Open: Oil deals and awaiting tech earningsTwo experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News medical contributor, believes fresh data from Novo Nordisk…
Read more ‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdlesA LVMH Moet Hennessy Louis Vuitton SE store in Shanghai, China on Wednesday, June 14, 2023. Bloomberg | Bloomberg | Getty Images Shares of LVMH dropped to their…
Read more LVMH shares fall to 2023 low as growth slows, pulling luxury sector downThe snack aisle is seen during a tour of a new Amazon Go store in the Capitol Hill neighborhood of Seattle, Washington, U.S., on Monday, Feb. 24, 2020.…
Read more Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boomJ.M. Smucker ‘s plan to buy Twinkies -maker Hostess Brands is a risky move, if Morgan Stanley’s latest research is correct. The firm revisited its August call that…
Read more Bet against America’s love for junk food? Morgan Stanley sees tough times ahead for snack stocks like HostessWeight loss drugs are being assessed for their ability to treat conditions like dementia and addiction after a landmark study showed that Wegovy helped reduce the risk of…
Read more Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementiaPackages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty…
Read more Novo Nordisk’s Wegovy weight loss drug launches in the UKA selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters Wegovy,…
Read more Wegovy helps reduce heart failure symptoms in obese people, study saysA selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters…
Read more Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soarMarket Movers rounded up the best reactions from investors and analysts on Eli Lilly . The experts, including Jim Cramer , discussed the drugmaker after it reported second-quarter…
Read more Eli Lilly hits record high after earnings, Mounjaro hype. Here’s what the pros are sayingEvery weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Stocks sink Eli…
Read more Here’s what is behind the stock market’s selloff and what we’re doing about itMorgan Stanley has named several buy-rated global stocks it expects to beat the market. In a note to investors, it named stocks after asking analysts to pick from…
Read more Morgan Stanley picks ‘particularly high conviction’ global stocks it says the rest of the market is missingIn this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images…
Read more Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and WegovyYou can’t deny the buzz. Credit Suisse analyst Trung Huynh has combed through social media and is impressed by the awareness — and demand — for GLP-1 medications…
Read more Credit Suisse sees Eli Lilly headed higher as Mounjaro users espouse weight loss drug on social mediaLarge European companies reported bumper profits over the past two weeks. However, according to strategists at Bank of America, there were more downward than upward revisions of company…
Read more Here are 10 global stocks analyst love coming out of the earnings week, Bank of America says
